Report Detail
Global Tenofovir Disoproxil Fumarate API Market Growth 2022-2028
- RnM4478704 |
- 05 August, 2022 |
- Global |
- 125 Pages |
- LPI(LP Information) |
- Chemical & Material
The global market for Tenofovir Disoproxil Fumarate API is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
The APAC Tenofovir Disoproxil Fumarate API market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The United States Tenofovir Disoproxil Fumarate API market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The Europe Tenofovir Disoproxil Fumarate API market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The China Tenofovir Disoproxil Fumarate API market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
Global key Tenofovir Disoproxil Fumarate API players cover Mangalam Drugs & Organics Ltd, Jai Radhe Sales, NEWEDGE Overseas, Summit Pharmaceuticals Europe Srl and Zeon Health Industries, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
Report Coverage
This latest report provides a deep insight into the global Tenofovir Disoproxil Fumarate API market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global Tenofovir Disoproxil Fumarate API market, with both quantitative and qualitative data, to help readers understand how the Tenofovir Disoproxil Fumarate API market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions and volume in Kg.
Market Segmentation:
The study segments the Tenofovir Disoproxil Fumarate API market and forecasts the market size by Purity (Above 98 % and Above 99 %,), by Application (Tablets and Others.), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by purity
Above 98 %
Above 99 %
Segmentation by application
Tablets
Others
Segmentation by region
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Major companies covered
Mangalam Drugs & Organics Ltd
Jai Radhe Sales
NEWEDGE Overseas
Summit Pharmaceuticals Europe Srl
Zeon Health Industries
Gonane Pharma
Aurisco Pharmaceutical Co.,Ltd
Tyche Industries Ltd
Styrax
Shanghai Desano Bio-Pharmaceutical
Zhejiang Supor Pharmaceuticals
Hetero Drugs
Lupin Ltd
Emcure Pharmaceuticals
Acebright India Pharma Private Limited
Chromo Laboratories
Blanver
Hana Pharm
Nortec Chemistry
Mylan
Chapter Introduction
Chapter 1: Scope of Tenofovir Disoproxil Fumarate API, Research Methodology, etc.
Chapter 2: Executive Summary, global Tenofovir Disoproxil Fumarate API market size (sales and revenue) and CAGR, Tenofovir Disoproxil Fumarate API market size by region, by purity, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Tenofovir Disoproxil Fumarate API sales, revenue, average price, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Tenofovir Disoproxil Fumarate API sales and revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, sales segment by country, by purity, and purity.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Tenofovir Disoproxil Fumarate API market size forecast by region, by country, by purity, and application.
Chapter 13: Comprehensive company profiles of the leading players, including Mangalam Drugs & Organics Ltd, Jai Radhe Sales, NEWEDGE Overseas, Summit Pharmaceuticals Europe Srl, Zeon Health Industries, Gonane Pharma, Aurisco Pharmaceutical Co.,Ltd, Tyche Industries Ltd and Styrax, etc.
Chapter 14: Research Findings and Conclusion
1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Years Considered
- 1.3 Research Objectives
- 1.4 Market Research Methodology
- 1.5 Research Process and Data Source
- 1.6 Economic Indicators
- 1.7 Currency Considered
2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global Tenofovir Disoproxil Fumarate API Annual Sales 2017-2028
- 2.1.2 World Current & Future Analysis for Tenofovir Disoproxil Fumarate API by Geographic Region, 2017, 2022 & 2028
- 2.1.3 World Current & Future Analysis for Tenofovir Disoproxil Fumarate API by Country/Region, 2017, 2022 & 2028
- 2.2 Tenofovir Disoproxil Fumarate API Segment by Purity
- 2.2.1 Above 98 %
- 2.2.2 Above 99 %
- 2.3 Tenofovir Disoproxil Fumarate API Sales by Purity
- 2.3.1 Global Tenofovir Disoproxil Fumarate API Sales Market Share by Purity (2017-2022)
- 2.3.2 Global Tenofovir Disoproxil Fumarate API Revenue and Market Share by Purity (2017-2022)
- 2.3.3 Global Tenofovir Disoproxil Fumarate API Sale Price by Purity (2017-2022)
- 2.4 Tenofovir Disoproxil Fumarate API Segment by Application
- 2.4.1 Tablets
- 2.4.2 Others
- 2.5 Tenofovir Disoproxil Fumarate API Sales by Application
- 2.5.1 Global Tenofovir Disoproxil Fumarate API Sale Market Share by Application (2017-2022)
- 2.5.2 Global Tenofovir Disoproxil Fumarate API Revenue and Market Share by Application (2017-2022)
- 2.5.3 Global Tenofovir Disoproxil Fumarate API Sale Price by Application (2017-2022)
3 Global Tenofovir Disoproxil Fumarate API by Company
- 3.1 Global Tenofovir Disoproxil Fumarate API Breakdown Data by Company
- 3.1.1 Global Tenofovir Disoproxil Fumarate API Annual Sales by Company (2020-2022)
- 3.1.2 Global Tenofovir Disoproxil Fumarate API Sales Market Share by Company (2020-2022)
- 3.2 Global Tenofovir Disoproxil Fumarate API Annual Revenue by Company (2020-2022)
- 3.2.1 Global Tenofovir Disoproxil Fumarate API Revenue by Company (2020-2022)
- 3.2.2 Global Tenofovir Disoproxil Fumarate API Revenue Market Share by Company (2020-2022)
- 3.3 Global Tenofovir Disoproxil Fumarate API Sale Price by Company
- 3.4 Key Manufacturers Tenofovir Disoproxil Fumarate API Producing Area Distribution, Sales Area, Product Type
- 3.4.1 Key Manufacturers Tenofovir Disoproxil Fumarate API Product Location Distribution
- 3.4.2 Players Tenofovir Disoproxil Fumarate API Products Offered
- 3.5 Market Concentration Rate Analysis
- 3.5.1 Competition Landscape Analysis
- 3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
- 3.6 New Products and Potential Entrants
- 3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Tenofovir Disoproxil Fumarate API by Geographic Region
- 4.1 World Historic Tenofovir Disoproxil Fumarate API Market Size by Geographic Region (2017-2022)
- 4.1.1 Global Tenofovir Disoproxil Fumarate API Annual Sales by Geographic Region (2017-2022)
- 4.1.2 Global Tenofovir Disoproxil Fumarate API Annual Revenue by Geographic Region
- 4.2 World Historic Tenofovir Disoproxil Fumarate API Market Size by Country/Region (2017-2022)
- 4.2.1 Global Tenofovir Disoproxil Fumarate API Annual Sales by Country/Region (2017-2022)
- 4.2.2 Global Tenofovir Disoproxil Fumarate API Annual Revenue by Country/Region
- 4.3 Americas Tenofovir Disoproxil Fumarate API Sales Growth
- 4.4 APAC Tenofovir Disoproxil Fumarate API Sales Growth
- 4.5 Europe Tenofovir Disoproxil Fumarate API Sales Growth
- 4.6 Middle East & Africa Tenofovir Disoproxil Fumarate API Sales Growth
5 Americas
- 5.1 Americas Tenofovir Disoproxil Fumarate API Sales by Country
- 5.1.1 Americas Tenofovir Disoproxil Fumarate API Sales by Country (2017-2022)
- 5.1.2 Americas Tenofovir Disoproxil Fumarate API Revenue by Country (2017-2022)
- 5.2 Americas Tenofovir Disoproxil Fumarate API Sales by Purity
- 5.3 Americas Tenofovir Disoproxil Fumarate API Sales by Application
- 5.4 United States
- 5.5 Canada
- 5.6 Mexico
- 5.7 Brazil
6 APAC
- 6.1 APAC Tenofovir Disoproxil Fumarate API Sales by Region
- 6.1.1 APAC Tenofovir Disoproxil Fumarate API Sales by Region (2017-2022)
- 6.1.2 APAC Tenofovir Disoproxil Fumarate API Revenue by Region (2017-2022)
- 6.2 APAC Tenofovir Disoproxil Fumarate API Sales by Purity
- 6.3 APAC Tenofovir Disoproxil Fumarate API Sales by Application
- 6.4 China
- 6.5 Japan
- 6.6 South Korea
- 6.7 Southeast Asia
- 6.8 India
- 6.9 Australia
- 6.10 China Taiwan
7 Europe
- 7.1 Europe Tenofovir Disoproxil Fumarate API by Country
- 7.1.1 Europe Tenofovir Disoproxil Fumarate API Sales by Country (2017-2022)
- 7.1.2 Europe Tenofovir Disoproxil Fumarate API Revenue by Country (2017-2022)
- 7.2 Europe Tenofovir Disoproxil Fumarate API Sales by Purity
- 7.3 Europe Tenofovir Disoproxil Fumarate API Sales by Application
- 7.4 Germany
- 7.5 France
- 7.6 UK
- 7.7 Italy
- 7.8 Russia
8 Middle East & Africa
- 8.1 Middle East & Africa Tenofovir Disoproxil Fumarate API by Country
- 8.1.1 Middle East & Africa Tenofovir Disoproxil Fumarate API Sales by Country (2017-2022)
- 8.1.2 Middle East & Africa Tenofovir Disoproxil Fumarate API Revenue by Country (2017-2022)
- 8.2 Middle East & Africa Tenofovir Disoproxil Fumarate API Sales by Purity
- 8.3 Middle East & Africa Tenofovir Disoproxil Fumarate API Sales by Application
- 8.4 Egypt
- 8.5 South Africa
- 8.6 Israel
- 8.7 Turkey
- 8.8 GCC Countries
9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers & Growth Opportunities
- 9.2 Market Challenges & Risks
- 9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
- 10.1 Raw Material and Suppliers
- 10.2 Manufacturing Cost Structure Analysis of Tenofovir Disoproxil Fumarate API
- 10.3 Manufacturing Process Analysis of Tenofovir Disoproxil Fumarate API
- 10.4 Industry Chain Structure of Tenofovir Disoproxil Fumarate API
11 Marketing, Distributors and Customer
- 11.1 Sales Channel
- 11.1.1 Direct Channels
- 11.1.2 Indirect Channels
- 11.2 Tenofovir Disoproxil Fumarate API Distributors
- 11.3 Tenofovir Disoproxil Fumarate API Customer
12 World Forecast Review for Tenofovir Disoproxil Fumarate API by Geographic Region
- 12.1 Global Tenofovir Disoproxil Fumarate API Market Size Forecast by Region
- 12.1.1 Global Tenofovir Disoproxil Fumarate API Forecast by Region (2023-2028)
- 12.1.2 Global Tenofovir Disoproxil Fumarate API Annual Revenue Forecast by Region (2023-2028)
- 12.2 Americas Forecast by Country
- 12.3 APAC Forecast by Region
- 12.4 Europe Forecast by Country
- 12.5 Middle East & Africa Forecast by Country
- 12.6 Global Tenofovir Disoproxil Fumarate API Forecast by Purity
- 12.7 Global Tenofovir Disoproxil Fumarate API Forecast by Application
13 Key Players Analysis
- 13.1 Mangalam Drugs & Organics Ltd
- 13.1.1 Mangalam Drugs & Organics Ltd Company Information
- 13.1.2 Mangalam Drugs & Organics Ltd Tenofovir Disoproxil Fumarate API Product Offered
- 13.1.3 Mangalam Drugs & Organics Ltd Tenofovir Disoproxil Fumarate API Sales, Revenue, Price and Gross Margin (2020-2022)
- 13.1.4 Mangalam Drugs & Organics Ltd Main Business Overview
- 13.1.5 Mangalam Drugs & Organics Ltd Latest Developments
- 13.2 Jai Radhe Sales
- 13.2.1 Jai Radhe Sales Company Information
- 13.2.2 Jai Radhe Sales Tenofovir Disoproxil Fumarate API Product Offered
- 13.2.3 Jai Radhe Sales Tenofovir Disoproxil Fumarate API Sales, Revenue, Price and Gross Margin (2020-2022)
- 13.2.4 Jai Radhe Sales Main Business Overview
- 13.2.5 Jai Radhe Sales Latest Developments
- 13.3 NEWEDGE Overseas
- 13.3.1 NEWEDGE Overseas Company Information
- 13.3.2 NEWEDGE Overseas Tenofovir Disoproxil Fumarate API Product Offered
- 13.3.3 NEWEDGE Overseas Tenofovir Disoproxil Fumarate API Sales, Revenue, Price and Gross Margin (2020-2022)
- 13.3.4 NEWEDGE Overseas Main Business Overview
- 13.3.5 NEWEDGE Overseas Latest Developments
- 13.4 Summit Pharmaceuticals Europe Srl
- 13.4.1 Summit Pharmaceuticals Europe Srl Company Information
- 13.4.2 Summit Pharmaceuticals Europe Srl Tenofovir Disoproxil Fumarate API Product Offered
- 13.4.3 Summit Pharmaceuticals Europe Srl Tenofovir Disoproxil Fumarate API Sales, Revenue, Price and Gross Margin (2020-2022)
- 13.4.4 Summit Pharmaceuticals Europe Srl Main Business Overview
- 13.4.5 Summit Pharmaceuticals Europe Srl Latest Developments
- 13.5 Zeon Health Industries
- 13.5.1 Zeon Health Industries Company Information
- 13.5.2 Zeon Health Industries Tenofovir Disoproxil Fumarate API Product Offered
- 13.5.3 Zeon Health Industries Tenofovir Disoproxil Fumarate API Sales, Revenue, Price and Gross Margin (2020-2022)
- 13.5.4 Zeon Health Industries Main Business Overview
- 13.5.5 Zeon Health Industries Latest Developments
- 13.6 Gonane Pharma
- 13.6.1 Gonane Pharma Company Information
- 13.6.2 Gonane Pharma Tenofovir Disoproxil Fumarate API Product Offered
- 13.6.3 Gonane Pharma Tenofovir Disoproxil Fumarate API Sales, Revenue, Price and Gross Margin (2020-2022)
- 13.6.4 Gonane Pharma Main Business Overview
- 13.6.5 Gonane Pharma Latest Developments
- 13.7 Aurisco Pharmaceutical Co.,Ltd
- 13.7.1 Aurisco Pharmaceutical Co.,Ltd Company Information
- 13.7.2 Aurisco Pharmaceutical Co.,Ltd Tenofovir Disoproxil Fumarate API Product Offered
- 13.7.3 Aurisco Pharmaceutical Co.,Ltd Tenofovir Disoproxil Fumarate API Sales, Revenue, Price and Gross Margin (2020-2022)
- 13.7.4 Aurisco Pharmaceutical Co.,Ltd Main Business Overview
- 13.7.5 Aurisco Pharmaceutical Co.,Ltd Latest Developments
- 13.8 Tyche Industries Ltd
- 13.8.1 Tyche Industries Ltd Company Information
- 13.8.2 Tyche Industries Ltd Tenofovir Disoproxil Fumarate API Product Offered
- 13.8.3 Tyche Industries Ltd Tenofovir Disoproxil Fumarate API Sales, Revenue, Price and Gross Margin (2020-2022)
- 13.8.4 Tyche Industries Ltd Main Business Overview
- 13.8.5 Tyche Industries Ltd Latest Developments
- 13.9 Styrax
- 13.9.1 Styrax Company Information
- 13.9.2 Styrax Tenofovir Disoproxil Fumarate API Product Offered
- 13.9.3 Styrax Tenofovir Disoproxil Fumarate API Sales, Revenue, Price and Gross Margin (2020-2022)
- 13.9.4 Styrax Main Business Overview
- 13.9.5 Styrax Latest Developments
- 13.10 Shanghai Desano Bio-Pharmaceutical
- 13.10.1 Shanghai Desano Bio-Pharmaceutical Company Information
- 13.10.2 Shanghai Desano Bio-Pharmaceutical Tenofovir Disoproxil Fumarate API Product Offered
- 13.10.3 Shanghai Desano Bio-Pharmaceutical Tenofovir Disoproxil Fumarate API Sales, Revenue, Price and Gross Margin (2020-2022)
- 13.10.4 Shanghai Desano Bio-Pharmaceutical Main Business Overview
- 13.10.5 Shanghai Desano Bio-Pharmaceutical Latest Developments
- 13.11 Zhejiang Supor Pharmaceuticals
- 13.11.1 Zhejiang Supor Pharmaceuticals Company Information
- 13.11.2 Zhejiang Supor Pharmaceuticals Tenofovir Disoproxil Fumarate API Product Offered
- 13.11.3 Zhejiang Supor Pharmaceuticals Tenofovir Disoproxil Fumarate API Sales, Revenue, Price and Gross Margin (2020-2022)
- 13.11.4 Zhejiang Supor Pharmaceuticals Main Business Overview
- 13.11.5 Zhejiang Supor Pharmaceuticals Latest Developments
- 13.12 Hetero Drugs
- 13.12.1 Hetero Drugs Company Information
- 13.12.2 Hetero Drugs Tenofovir Disoproxil Fumarate API Product Offered
- 13.12.3 Hetero Drugs Tenofovir Disoproxil Fumarate API Sales, Revenue, Price and Gross Margin (2020-2022)
- 13.12.4 Hetero Drugs Main Business Overview
- 13.12.5 Hetero Drugs Latest Developments
- 13.13 Lupin Ltd
- 13.13.1 Lupin Ltd Company Information
- 13.13.2 Lupin Ltd Tenofovir Disoproxil Fumarate API Product Offered
- 13.13.3 Lupin Ltd Tenofovir Disoproxil Fumarate API Sales, Revenue, Price and Gross Margin (2020-2022)
- 13.13.4 Lupin Ltd Main Business Overview
- 13.13.5 Lupin Ltd Latest Developments
- 13.14 Emcure Pharmaceuticals
- 13.14.1 Emcure Pharmaceuticals Company Information
- 13.14.2 Emcure Pharmaceuticals Tenofovir Disoproxil Fumarate API Product Offered
- 13.14.3 Emcure Pharmaceuticals Tenofovir Disoproxil Fumarate API Sales, Revenue, Price and Gross Margin (2020-2022)
- 13.14.4 Emcure Pharmaceuticals Main Business Overview
- 13.14.5 Emcure Pharmaceuticals Latest Developments
- 13.15 Acebright India Pharma Private Limited
- 13.15.1 Acebright India Pharma Private Limited Company Information
- 13.15.2 Acebright India Pharma Private Limited Tenofovir Disoproxil Fumarate API Product Offered
- 13.15.3 Acebright India Pharma Private Limited Tenofovir Disoproxil Fumarate API Sales, Revenue, Price and Gross Margin (2020-2022)
- 13.15.4 Acebright India Pharma Private Limited Main Business Overview
- 13.15.5 Acebright India Pharma Private Limited Latest Developments
- 13.16 Chromo Laboratories
- 13.16.1 Chromo Laboratories Company Information
- 13.16.2 Chromo Laboratories Tenofovir Disoproxil Fumarate API Product Offered
- 13.16.3 Chromo Laboratories Tenofovir Disoproxil Fumarate API Sales, Revenue, Price and Gross Margin (2020-2022)
- 13.16.4 Chromo Laboratories Main Business Overview
- 13.16.5 Chromo Laboratories Latest Developments
- 13.17 Blanver
- 13.17.1 Blanver Company Information
- 13.17.2 Blanver Tenofovir Disoproxil Fumarate API Product Offered
- 13.17.3 Blanver Tenofovir Disoproxil Fumarate API Sales, Revenue, Price and Gross Margin (2020-2022)
- 13.17.4 Blanver Main Business Overview
- 13.17.5 Blanver Latest Developments
- 13.18 Hana Pharm
- 13.18.1 Hana Pharm Company Information
- 13.18.2 Hana Pharm Tenofovir Disoproxil Fumarate API Product Offered
- 13.18.3 Hana Pharm Tenofovir Disoproxil Fumarate API Sales, Revenue, Price and Gross Margin (2020-2022)
- 13.18.4 Hana Pharm Main Business Overview
- 13.18.5 Hana Pharm Latest Developments
- 13.19 Nortec Quimica
- 13.19.1 Nortec Quimica Company Information
- 13.19.2 Nortec Quimica Tenofovir Disoproxil Fumarate API Product Offered
- 13.19.3 Nortec Quimica Tenofovir Disoproxil Fumarate API Sales, Revenue, Price and Gross Margin (2020-2022)
- 13.19.4 Nortec Quimica Main Business Overview
- 13.19.5 Nortec Quimica Latest Developments
- 13.20 Mylan
- 13.20.1 Mylan Company Information
- 13.20.2 Mylan Tenofovir Disoproxil Fumarate API Product Offered
- 13.20.3 Mylan Tenofovir Disoproxil Fumarate API Sales, Revenue, Price and Gross Margin (2020-2022)
- 13.20.4 Mylan Main Business Overview
- 13.20.5 Mylan Latest Developments
14 Research Findings and Conclusion
Summary:
Get latest Market Research Reports on Tenofovir Disoproxil Fumarate API. Industry analysis & Market Report on Tenofovir Disoproxil Fumarate API is a syndicated market report, published as Global Tenofovir Disoproxil Fumarate API Market Growth 2022-2028. It is complete Research Study and Industry Analysis of Tenofovir Disoproxil Fumarate API market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
